1-tert-butyl 4-ethyl 3-phenylpiperidine-1,4-dicarboxylate | 860472-88-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 1-tert-butyl 4-ethyl 3-phenylpiperidine-1,4-dicarboxylate
• 英文别名: (3SR,4RS)-3-Phenyl-piperidine-1,4-dicarboxylic acid 1-tert-butyl ester 4-ethyl ester；4-ethyl 1-tert-butyl (3R*,4S*)-3-phenylpiperidine-1,4-dicarboxylate；4-Ethyl 1-tert-butyl 3-phenylpiperidine-1,4-dicarboxylate；1-O-tert-butyl 4-O-ethyl 3-phenylpiperidine-1,4-dicarboxylate
• CAS: 860472-88-4
• 化学式: C₁₉H₂₇NO₄
• 分子量: 333.428
• InChiKey: RUKNPFBJQDRKIS-UHFFFAOYSA-N

物化性质

• 沸点：
  425.8±45.0 °C(Predicted)
• 密度：
  1.100±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.58
• 拓扑面积：
  55.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-tert-butyl 4-ethyl 3-phenylpiperidine-1,4-dicarboxylate 在 水 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 、 三氟乙酸 、 potassium hydroxide 、 sodium t-butanolate 作用下， 以 四氢呋喃 、 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 16.0h， 生成 (3RS,4SR)-1-acetyl-N-[3,5-bis(trifluoromethyl)benzyl]-N-methyl-3-phenylpiperidine-4-carboxamide
  参考文献：
  名称：

  Novel 3-phenylpiperidine-4-carboxamides as highly potent and orally long-acting neurokinin-1 receptor antagonists with reduced CYP3A induction

  摘要：

  The synthesis and biological evaluation of a series of novel 3-phenylpiperidine-4-carboxamide derivatives are described. These compounds are generated by hybridization of the substructures from two types of tachykinin NK1 receptor antagonists. Compound 42 showed high metabolic stability and excellent efficacy in the guinea-pig GR-73637-induced locomotive activity assay at 1 and 24 h after oral administration. It also exhibited good pharmacokinetic profiles in four animal species, and a low potential in a pregnane X receptor induction assay. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.11.048
• 作为产物：
  描述：

  1-苄基-3-氧杂-4-哌啶甲酸乙酯 在 四(三苯基膦)钯 、 palladium 10% on activated carbon 氢气 、 sodium hydride 、 potassium carbonate 、 溶剂黄146 作用下， 以 四氢呋喃 、 乙醚 、 乙醇 、 水 为溶剂， 20.0~65.0 ℃ 、344.75 kPa 条件下， 反应 3.0h， 生成 1-tert-butyl 4-ethyl 3-phenylpiperidine-1,4-dicarboxylate
  参考文献：
  名称：

  WO2008/120093

  摘要：

  公开号：

文献信息

• PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS
  申请人：Knust Henner

  公开号：US20100197697A1

  公开（公告）日：2010-08-05

  The present invention relates to a compounds of formula I wherein A, Ar 1 , Ar 2 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , m, n, o, p, s, t, and u are as defined herein or to a pharmaceutically active salt, a racemic mixture, an enantiomer, an optical isomer or a tautomeric form thereof. the present compounds are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).

  本发明涉及一种具有以下结构的化合物I，其中A、Ar1、Ar2、R1、R2、R3、R4、R5、R6、m、n、o、p、s、t和u如本文所定义，或者与其药效活性盐、外消旋体混合物、对映体、光学异构体或其互变异构体有关。本化合物是治疗抑郁症、疼痛、精神病、帕金森病、精神分裂症、焦虑和注意缺陷多动障碍（ADHD）的高潜力NK-3受体拮抗剂。
• Nitrogen-containing heterocyclic compound and use thereof
  申请人：Ikeura Yoshinori

  公开号：US20090156572A1

  公开（公告）日：2009-06-18

  The present invention relates to a compound represented by the formula wherein ring A is a nitrogen-containing heterocycle optionally further having substituent(s), ring B is an aromatic ring optionally having substituent(s), ring C is a cyclic group optionally having substituent(s), R 1 is a hydrogen atom, a hydrocarbon group optionally having substituent(s), an acyl group, a heterocyclic group optionally having substituent(s) or an amino group optionally having substituent(s), R 2 is an optionally halogenated C 1-6 alkyl group, m and n are each an integer of 0 to 5, m+n is an integer of 2 to 5, and is a single bond or a double bond, or a salt thereof and the like. Since the compound has a superior tachykinin receptor antagonistic action, and is useful as an agent for the prophylaxis or treatment of various diseases such as lower urinary tract diseases, gastrointestinal diseases, central nervous system diseases and the like.

  本发明涉及一种由下式表示的化合物：其中环A是含氮杂环，可选择地进一步具有取代基，环B是芳香环，可选择地具有取代基，环C是环状基团，可选择地具有取代基，R1是氢原子，一个碳氢基团，可选择地具有取代基，酰基，一个杂环基团，可选择地具有取代基或一个氨基团，可选择地具有取代基，R2是可选择卤代的C1-6烷基基团，m和n分别是0到5的整数，m+n是2到5的整数，是单键或双键，或其盐等。由于该化合物具有优越的催吐肽受体拮抗作用，可用作预防或治疗多种疾病的药物，如下尿道疾病、胃肠道疾病、中枢神经系统疾病等。
• Sulfonamides and Pharmaceutical Compositions Thereof
  申请人：Estep Kimberly Gail

  公开号：US20100035865A1

  公开（公告）日：2010-02-11

  The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula (I), as defined in the specification. The invention is also directed to compositions containing the compounds of formula (I).

  本发明涉及一类化合物，包括化合物的药学上可接受的盐，具有公式(I)所定义的结构，本发明还涉及含有公式(I)化合物的组合物。
• Carboxamide derivative and use thereof
  申请人：Ikeura Yoshinori

  公开号：US20090186874A1

  公开（公告）日：2009-07-23

  The present invention relates to a compound represented by the formula wherein ring A is a nitrogen-containing heterocycle optionally further having substituent(s), ring B and ring C are each an aromatic ring optionally having substituent(s), R 1 is a hydrogen atom, a hydrocarbon group optionally having substituent(s), an acyl group or a heterocyclic group optionally having substituent(s), Z is an optionally halogenated C 1-6 alkyl group, Y is a methylene group optionally having substituent(s), m and n are each an integer of 0 to 5, m+n is an integer of 2 to 5, and is a single bond or a double bond, or a salt thereof. The compound of the present invention has a superior tachykinin receptor antagonistic action, particularly an SP receptor antagonistic action, and is useful as a pharmaceutical agent, for example, a tachykinin receptor antagonist, an agent for the prophylaxis or treatment of an abnormality of lower urinary tract functions, a digestive organ disease or a central nerve disease, and the like.

  本发明涉及一种化合物，其表示为以下式子： 其中，环A是一种含氮杂环，可以选择进一步具有取代基；环B和环C分别是芳香环，可以选择进一步具有取代基；R1是氢原子，一个碳氢基团，可以选择进一步具有取代基，一个酰基基团或一个杂环基团，可以选择进一步具有取代基；Z是一个可选择卤代的C1-6烷基基团，Y是一个可选择具有取代基的亚甲基基团，m和n均为0到5的整数，m+n是2到5的整数，且是单键或双键，或其盐。本发明的化合物具有优异的速激肽受体拮抗作用，特别是SP受体拮抗作用，并且可用作制药剂，例如速激肽受体拮抗剂，预防或治疗下尿路功能异常、消化器官疾病或中枢神经疾病等。
• CARBOXAMIDE DERIVATIVE AND USE THEREOF
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP1705176A1

  公开（公告）日：2006-09-27

  The present invention relates to a compound represented by the formula wherein ring A is a nitrogen-containing heterocycle optionally further having substituent(s), ring B and ring C are each an aromatic ring optionally having substituent(s), R1 is a hydrogen atom, a hydrocarbon group optionally having substituent(s), an acyl group or a heterocyclic group optionally having substituent(s), Z is an optionally halogenated C1-6 alkyl group, Y is a methylene group optionally having substituent(s), m and n are each an integer of 0 to 5, m+n is an integer of 2 to 5, and is a single bond or a double bond, or a salt thereof. The compound of the present invention has a superior tachykinin receptor antagonistic action, particularly an SP receptor antagonistic action, and is useful as a pharmaceutical agent, for example, a tachykinin receptor antagonist, an agent for the prophylaxis or treatment of an abnormality of lower urinary tract functions, a digestive organ disease or a central nerve disease, and the like.

  本发明涉及一种由式表示的化合物 其中环 A 是可选进一步具有取代基的含氮杂环，环 B 和环 C 各是可选具有取代基的芳香环，R1 是氢原子、可选具有取代基的烃基、酰基或可选具有取代基的杂环基团，Z 是可选被卤化的 C1-6 烷基，R2 是可选被卤化的 C1-6 烷基，R3 是可选被卤化的 C1-6 烷基，R4 是可选被卤化的 C1-6 烷基、Z 是可选的卤代 C1-6 烷基，Y 是可选的亚甲基，m 和 n 分别是 0 至 5 的整数，m+n 是 2 至 5 的整数，并且是单键或双键，或其盐。本发明的化合物具有优异的速激肽受体拮抗作用，特别是 SP 受体拮抗作用，可用作药物制剂，例如速激肽受体拮抗剂，预防或治疗下尿路功能异常、消化器官疾病或中枢神经疾病等的药物。